321 related articles for article (PubMed ID: 22044885)
1. Targeting Eph receptors with peptides and small molecules: progress and challenges.
Noberini R; Lamberto I; Pasquale EB
Semin Cell Dev Biol; 2012 Feb; 23(1):51-7. PubMed ID: 22044885
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Eph System with Peptides and Peptide Conjugates.
Riedl SJ; Pasquale EB
Curr Drug Targets; 2015; 16(10):1031-47. PubMed ID: 26212263
[TBL] [Abstract][Full Text] [Related]
3. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.
Noberini R; De SK; Zhang Z; Wu B; Raveendra-Panickar D; Chen V; Vazquez J; Qin H; Song J; Cosford ND; Pellecchia M; Pasquale EB
Chem Biol Drug Des; 2011 Oct; 78(4):667-78. PubMed ID: 21791013
[TBL] [Abstract][Full Text] [Related]
4. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
[TBL] [Abstract][Full Text] [Related]
5. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
6. Eph receptor tyrosine kinases in cancer stem cells.
Chen J; Song W; Amato K
Cytokine Growth Factor Rev; 2015 Feb; 26(1):1-6. PubMed ID: 24933439
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of targeting the Eph/ephrin signaling complex.
Saha N; Robev D; Mason EO; Himanen JP; Nikolov DB
Int J Biochem Cell Biol; 2018 Dec; 105():123-133. PubMed ID: 30343150
[TBL] [Abstract][Full Text] [Related]
8. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
9. Ephrin or not? Six tough questions on Eph targeting.
Giorgio C; Zanotti I; Lodola A; Tognolini M
Expert Opin Ther Targets; 2020 May; 24(5):403-415. PubMed ID: 32197575
[No Abstract] [Full Text] [Related]
10. Eph receptors as therapeutic targets in glioblastoma.
Day BW; Stringer BW; Boyd AW
Br J Cancer; 2014 Sep; 111(7):1255-61. PubMed ID: 25144626
[TBL] [Abstract][Full Text] [Related]
11. Ephrin-Eph signaling usage by a variety of viruses.
de Boer ECW; van Gils JM; van Gils MJ
Pharmacol Res; 2020 Sep; 159():105038. PubMed ID: 32565311
[TBL] [Abstract][Full Text] [Related]
12. Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers.
Lau A; Le N; Nguyen C; Kandpal RP
Cell Signal; 2023 Apr; 104():110579. PubMed ID: 36572189
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting Eph kinase activity may not be "Eph"ective for cancer treatment.
Herington AC; Mertens-Walker I; Lisle JE; Maharaj M; Stephenson SA
Growth Factors; 2014 Dec; 32(6):207-13. PubMed ID: 25413947
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.
Noberini R; Koolpe M; Lamberto I; Pasquale EB
Pharmacol Res; 2012 Oct; 66(4):363-73. PubMed ID: 22750215
[TBL] [Abstract][Full Text] [Related]
15. Targeting Eph/ephrin system in cancer therapy.
Lodola A; Giorgio C; Incerti M; Zanotti I; Tognolini M
Eur J Med Chem; 2017 Dec; 142():152-162. PubMed ID: 28780190
[TBL] [Abstract][Full Text] [Related]
16. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
17. The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment.
Buckens OJ; El Hassouni B; Giovannetti E; Peters GJ
Expert Opin Investig Drugs; 2020 Jun; 29(6):567-582. PubMed ID: 32348169
[TBL] [Abstract][Full Text] [Related]
18. The first identification of complete Eph-ephrin signalling in ctenophores and sponges reveals a role for neofunctionalization in the emergence of signalling domains.
Krishnan A; Degnan BM; Degnan SM
BMC Evol Biol; 2019 Apr; 19(1):96. PubMed ID: 31023220
[TBL] [Abstract][Full Text] [Related]
19. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
Koolpe M; Burgess R; Dail M; Pasquale EB
J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342
[TBL] [Abstract][Full Text] [Related]
20. Eph receptors and ephrins as targets for cancer therapy.
Xi HQ; Wu XS; Wei B; Chen L
J Cell Mol Med; 2012 Dec; 16(12):2894-909. PubMed ID: 22862837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
